2022
DOI: 10.21037/tcr-21-1841
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment

Abstract: Background: The interaction between cancer cells and stromal cells has a significant contribution in tumorigenesis and tumor development, and plays an anti-tumor immune effect under the regulation of drug resistance-related genes, which affects the outcome of patients. Coiled-coil domain-containing protein 73 (CCDC73), DLG associated protein 1 (DLGAP1), dermatan sulfate epimerase like (DSEL), estrogen receptor 1 (ESR1), and SEC14-like 5 (SEC14L5) were identified as drug resistance-related genes in lung cancer.… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…Immune-checkpoint inhibitors are widely used for lung cancer treatment [1]; therefore, the number of studies on the effects of estrogen on tumor immunity in lung cancer is increasing and data analyses using public databases have shown that ER and/or PgR expression in cancer tissues correlate with immune cell infiltration. Zhu et al reported that ERα expression is positively correlated with the infiltration of dendritic cells, macrophages, neutrophils, B cells, CD4+ T cells, and CD8+ T cells; however, there is no correlation between ERα expression and the prognosis [80]. Oh et al analyzed RNA seauencing data from The Cancer Genome Atlas and demonstrated that increased ERα was associated with high expression of immune-checkpoint markers, whereas increased PgR was associated with high levels of TGF-β genes [81].…”
Section: Influence Of Female Hormones On Tumor Immunity In Nsclcmentioning
confidence: 99%
“…Immune-checkpoint inhibitors are widely used for lung cancer treatment [1]; therefore, the number of studies on the effects of estrogen on tumor immunity in lung cancer is increasing and data analyses using public databases have shown that ER and/or PgR expression in cancer tissues correlate with immune cell infiltration. Zhu et al reported that ERα expression is positively correlated with the infiltration of dendritic cells, macrophages, neutrophils, B cells, CD4+ T cells, and CD8+ T cells; however, there is no correlation between ERα expression and the prognosis [80]. Oh et al analyzed RNA seauencing data from The Cancer Genome Atlas and demonstrated that increased ERα was associated with high expression of immune-checkpoint markers, whereas increased PgR was associated with high levels of TGF-β genes [81].…”
Section: Influence Of Female Hormones On Tumor Immunity In Nsclcmentioning
confidence: 99%
“…To generate new hypotheses regarding the mechanism of cancer, we performed an analysis of the functions of the identified genes and their corresponding protein interaction networks. A previous study has shown that lung cancer patients with a high transcription level of the CCDC73 gene tend to have a good prognosis [32]. Another study found a relationship between the expression of the serotonin 2B (HTR2B) receptor and human uveal melanoma [33].…”
Section: Gene and Protein-knowledge-based Analysismentioning
confidence: 99%